Panel Discussion & Q&A: Will a regulated environment improve the dialogue on harm reduction

Time: 2:45 pm - 3:15 pm

Date: May 17 2022

may-17-2022 14:45 may-17-2022 15:15 Europe/London Panel Discussion & Q&A: Will a regulated environment improve the dialogue on harm reduction

Has the lack of federal regulation led to a “wild west” for lawmakers and industry? “Big Tobacco” v Vape Stores –what are the regulatory implications for both, what significance will this have Will there be enough PMTA approved products to meet adult demand? Will the PMTA process create a 2-tier product category and a black… Read more »

The E-Cigarette Summit USA
  • Has the lack of federal regulation led to a “wild west” for lawmakers and industry?
  • “Big Tobacco” v Vape Stores –what are the regulatory implications for both, what significance will this have
  • Will there be enough PMTA approved products to meet adult demand?
  • Will the PMTA process create a 2-tier product category and a black market?
  • Do people working in public health, Research and tobacco control know enough people who smoke?

Chair

  • Prof David L. Ashley Ph.D RADM (retired) US Public Health Service: Research Professor - School of Public Health - Georgia State University

Session Responder

  • Prof David Levy Professor of Oncology - Lombardl Comprehensive Cancer Center, Georgetown University

Speakers

  • Matthew R. Holman Director, Office of Science (OS),Center for Tobacco Products (CTP) - U.S. Food and Drug Administration
  • David Graham Chief Impact Officer - NJOY
  • Marc Slis Vape Shop Owner - Vaper & Former Smoker - Onboard Seismic QC
  • Clive Bates Director - Counterfactual Consulting Ltd
  • Prof Kathleen. S Hoke, J.D. Director of the Legal Resource Center for Public Health Policy - University of Maryland Carey School of Law

« Back